PUBLISHER: Grand View Research | PRODUCT CODE: 2089755
PUBLISHER: Grand View Research | PRODUCT CODE: 2089755
The global ADHD apps market size was valued at USD 1.9 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 6.7 billion by 2033, at a CAGR of 17.5% from 2026 to 2033. North America dominated the global market in 2025 and accounted for the largest revenue share of 47.2%. The increasing prevalence of ADHD among children, adolescents, and adults is significantly driving the demand for these applications.
Growing awareness regarding early diagnosis, mental health screening, and behavioral disorders has increased the adoption of digital tools for symptom monitoring, focus improvement, and behavioral management. For instance, in May 2026, Lumosity announced that the U.S. FDA granted 510(k) clearance to LumosityRx, a prescription digital therapeutic for adults with ADHD. The platform demonstrated statistically significant improvement in sustained and selective attention during a randomized, double-blind clinical trial involving over 500 participants.
Global ADHD Apps Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research, Inc. has segmented the global ADHD apps market report based on app type, user age group, platform, end use, and region: